Assenagon Asset Management »

Cytomx Therapeutics shares owned by Assenagon Asset Management

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Assenagon Asset Management from 13F filings

Historical chart of Assenagon Asset Management investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Assenagon Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $882k 405k 2.18
2023-12-31 $627k 405k 1.55
2023-09-30 $549k 426k 1.29
2023-06-30 $1.1M 668k 1.72
2023-03-31 $1.0M 668k 1.51
2022-12-31 $1.5M 915k 1.60
2022-09-30 $1.5M 1.1M 1.45
2021-09-30 $141k 28k 5.08
2021-06-30 $3.1M 493k 6.33
2021-03-31 $1.6M 204k 7.73
2020-12-31 $1.4M 219k 6.55
2020-09-30 $1.2M 173k 6.65
2020-06-30 $2.1M 254k 8.33
2019-12-31 $1.9M 225k 8.31
2019-09-30 $560k 76k 7.38
2019-06-30 $1.4M 124k 11.22
2018-09-30 $363k 20k 18.48